What is the recommended protocol for intravenous (IV) magnesium (Mg) replacement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Magnesium Replacement Protocol

For hypomagnesemia, administer 1-2 g IV magnesium sulfate over 15 minutes for acute replacement, followed by maintenance infusion of 1 g/hour for 24 hours if needed, with the rate not exceeding 150 mg/minute except in life-threatening situations. 1, 2

Dosing by Clinical Indication

Hypomagnesemia (General)

  • Mild deficiency: 1 g (8.12 mEq) IM every 6 hours for 4 doses, or 5 g added to 1 liter of fluid for slow IV infusion over 3 hours 2
  • Severe hypomagnesemia: Up to 250 mg/kg (approximately 2 mEq/kg) may be given IM within 4 hours if necessary 2
  • Acute replacement: 1-2 g IV over 15 minutes, followed by maintenance infusion of 1 g/hour for 24 hours if needed 1
  • The FDA label specifies that caution must be observed to prevent exceeding renal excretory capacity during deficiency treatment 2

Life-Threatening Arrhythmias

  • Torsades de pointes: 2 g IV as first-line therapy regardless of serum magnesium level 3
  • For pediatric patients: 25-50 mg/kg (maximum 2 g) given as bolus for pulseless torsades, or over 10-20 minutes for torsades with pulses 4
  • Repeat 2 g infusions may be necessary if episodes persist 3
  • Polymorphic VT with QT prolongation: 1-2 g IV over 15 minutes 1

Severe Refractory Asthma

  • Dose: 2 g IV magnesium sulfate over 20 minutes for patients with the most severe exacerbations who have failed initial bronchodilator therapy 3
  • Must be diluted to 20% or less concentration before administration 4
  • Do NOT use for mild or moderate asthma exacerbations as it shows no benefit 3

Preeclampsia/Eclampsia

  • Loading dose: 4-6 g IV over 20-30 minutes 1
  • Maintenance: 1-2 g/hour continuous infusion 1
  • Alternative FDA-approved regimen: 4-5 g IV in 250 mL fluid, with simultaneous IM doses of up to 10 g (5 g in each buttock), followed by 4-5 g IM into alternate buttocks every 4 hours as needed 2
  • Continue for 24 hours postpartum as standard recommendation 1
  • Target serum magnesium level of 6 mg/100 mL for seizure control 2

Administration Guidelines

Rate and Concentration

  • Maximum rate: Generally should not exceed 150 mg/minute (1.5 mL of 10% solution), except in severe eclampsia with seizures 2
  • Dilution requirement: Solutions for IV infusion must be diluted to 20% or less concentration prior to administration 2
  • Common diluents are 5% dextrose or 0.9% sodium chloride 2

Duration Considerations

  • A 2024 study found that 2 g doses maintain total serum magnesium above 2.0 mg/dL for less than 12 hours on average, suggesting twice-daily dosing may be needed for sustained therapeutic levels 5
  • Research shows that prolonging infusion rates (0.5 g/hour vs. 2 g/hour) does not improve magnesium retention or therapeutic outcomes 6

Safety Monitoring

Critical Precautions

  • Have calcium chloride immediately available to counteract magnesium toxicity 4
  • Monitor for hypotension, bradycardia, and flushing during administration 1
  • Check patellar reflexes and respiratory function before each IM dose in eclampsia management 2

Maximum Dosing Limits

  • Total daily dose: Should not exceed 30-40 g in 24 hours 2
  • Severe renal insufficiency: Maximum 20 g/48 hours with frequent serum magnesium monitoring 2
  • Pregnancy: Do not continue beyond 5-7 days as it can cause fetal abnormalities 2

Target Serum Levels

  • Therapeutic range: 1.5-3 mmol/L (approximately 3.6-7.3 mg/dL) for most indications 7
  • Maintenance therapy: Target 1.3-2.2 mEq/L 1
  • Eclampsia control: 6 mg/100 mL (approximately 2.5 mEq/L) 2

Special Populations

Short Bowel Syndrome

  • Rehydration to correct secondary hyperaldosteronism is the most important first step before magnesium replacement 4
  • If oral supplementation fails, give IV or subcutaneous magnesium (4-12 mmol added to saline bag) 4

Cancer Patients

  • Chemotherapy agents like cisplatin or cetuximab may cause significant hypomagnesemia requiring IV replacement 4
  • IV magnesium sulfate may reverse neurological symptoms including confusion, hallucinations, irritability, and seizures 4

Pediatric Dosing

  • For hypomagnesemia/torsades: 25-50 mg/kg (maximum 2 g) over 10-20 minutes 4
  • Rapid infusion may cause hypotension and bradycardia 4

Common Pitfalls

  • Inadequate maintenance dosing: An IV regimen with 1 g/hour maintenance is inadequate for preeclampsia management; 2 g/hour is required to achieve therapeutic levels comparable to IM regimens 8
  • Forgetting dilution: Always dilute to ≤20% concentration for IV infusion to prevent adverse effects 2
  • Ignoring renal function: Adjust dosing and increase monitoring frequency in renal insufficiency 2
  • Assuming single doses suffice: For sustained effect, expect to dose at least twice daily when targeting serum levels above 2.0 mg/dL 5

References

Guideline

Magnesium Sulfate Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Intravenous Magnesium Sulfate Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018

Research

Intravenous magnesium.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.